EdgarLookup

AXIM BIOTECHNOLOGIES, INC. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Valencia Catalina President and Director Purchase 1,086,216 28,608,220 Jan 30, 2024
Valencia Catalina Purchase 3,861,004 $0.03 $115,830 23,661,004 Aug 24, 2022
Schroeder Blake C 854,012 $0.03 $25,620 854,012 Aug 22, 2022
HUEMOELLER JOHN WALTER II Chief Executive Officer Purchase 6,000,000 6,000,000 Mar 19, 2020
MALASEK ROBERT CFO Award / Grant 50,000 50,000 Mar 21, 2018
Medical Marijuana Inc Award / Grant 500,000 500,000 Dec 2, 2016
Medical Marijuana Inc Award / Grant 500,000 500,000 Dec 2, 2016
Changoer Lekhram Award / Grant 240,000 2,265,000 Nov 21, 2016
Anastassov George CEO/Secretary Award / Grant 500,000 500,000 Nov 21, 2016
Anastassov George President Award / Grant 125,000 15,365,650 Feb 5, 2016
Changoer Lekhram Award / Grant 1,000,000 1,500,000 Dec 18, 2015
Anastassov George President Award / Grant 500,000 15,240,650 Nov 9, 2015
Anastassov George President Award / Grant 2,000 14,945,650 Feb 23, 2015
SAMUELS ROSEMARY PRESIDENT, CEO, CFO Sale 1,000,000 $400.00 $400,000,000 Mar 21, 2014